BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 20 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 20 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER 0.224% POTASSIUM CHLORIDE and 5% GLUCOSE 1000mL injection AHB1174 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.224% potassium chloride and 5% glucose 1000ml injection ahb1174

baxter healthcare pty ltd - glucose, quantity: 50 g/l; potassium chloride, quantity: 2.24 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the potassium chloride in glucose (5%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. this is also an alternative route of administration for the patients who are unable to take potassium orally or if hypokalaemia is severe. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.15% POTASSIUM CHLORIDE and 5% GLUCOSE 1L Injection BP AHB1134 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 5% glucose 1l injection bp ahb1134

baxter healthcare pty ltd - glucose, quantity: 50 g/l; potassium chloride, quantity: 1.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the potassium chloride in glucose (5%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. this is also an alternative route of administration for the patients who are unable to take potassium orally or if hypokalaemia is severe. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

SODIUM NITROPRUSSIDE BAXTER sodium nitroprusside 50 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sodium nitroprusside baxter sodium nitroprusside 50 mg/2 ml concentrated injection vial

baxter healthcare pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside baxter concentrated injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

BAXTER CARDIOPLEGIA SOLUTION A, 1000mL solution bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter cardioplegia solution a, 1000ml solution bag

baxter healthcare pty ltd - sodium chloride, quantity: 6.43 g/l; potassium chloride, quantity: 1.19 g/l; magnesium chloride hexahydrate, quantity: 3.25 g/l; calcium chloride dihydrate, quantity: 0.176 g/l - solution - excipient ingredients: water for injections; hydrochloric acid - other conditions: the ph of the solution must be adjusted to 7.4 to 7. 8 with 10ml of sodium bicarbonate 8.4% w/v injection bp (not supplied) before use. indications: following ph adjustment with 10ml of sodium bicarbonate 8.4% w/v injection bp, cardioplegia "a" solution is used in combination with ischaemia and hypothermia to induce cardiac arrest during open heart surgery and to preserve the myocardium during asystole.

Baxter 0.45% Sodium Chloride and 5% Glucose Intravenous Infusion 1000 mL bag (AHB6028) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 5% glucose intravenous infusion 1000 ml bag (ahb6028)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections; hydrochloric acid - sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 25% GLUCOSE 250mg/L injection AHB0224 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 25% glucose 250mg/l injection ahb0224

baxter healthcare pty ltd - glucose, quantity: 250 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)